Harout DerSimonian

Title: Harout DerSimonian: Innovator in Transgenic Research

Introduction

Harout DerSimonian is a prominent inventor based in Wellesley, MA (US). He has made significant contributions to the field of transgenic research, particularly in the development of methods that promote tolerance in swine grafts for human recipients. His innovative work has led to the filing of two patents.

Latest Patents

DerSimonian's latest patents include groundbreaking methods involving transgenic swine and swine cells that incorporate human HLA genes. One of his patents discloses methods for promoting tolerance and inhibiting NK cell-mediated attacks in human recipients of swine grafts. This involves introducing a swine hematopoietic stem cell transformed with a transgene encoding a human MHC class I protein, which effectively inhibits the recipient's NK cell-mediated attack. Another patent focuses on genetically engineered swine cells that contain a transgene encoding a human HLA protein.

Career Highlights

Harout DerSimonian is associated with The General Hospital Corporation, where he continues to advance his research in transgenic technologies. His work is pivotal in bridging the gap between animal and human medicine, particularly in transplantation science.

Collaborations

Some of his notable coworkers include Joerg Seebach and David H Sachs, who have collaborated with him on various research projects.

Conclusion

Harout DerSimonian's innovative contributions to transgenic research are shaping the future of transplantation and tolerance in medical science. His patents reflect a commitment to advancing the field and improving outcomes for patients in need of grafts.